Chiara Biosciences
Category: Drug Discovery
Campus: Weill Cornell Medicine
Incubator:
Chiara Biosciences is creating a new category of targeted protein degraders with its proprietary CURE-PRO™ platform, which uses a “puzzle-piece” approach to overcome the size and geometry limitations of first-generation degraders. The platform enables oral delivery, CNS penetration, and the rapid discovery of novel degrader pairs. Chiara’s unique combinatorial strategy supports a high throughput, reusable platform for developing both an internal pipeline and collaborative solutions for strategic CURE-PRO development.
Location: Colorado
Foundation Cornell Technology Licensed: 2025
Metro Mid-Atlantic Biotech, LLC
Category: Drug Discovery
Campus: Weill Cornell Medicine
Incubator:
Metro Mid-Atlantic Biotech is a development stage startup focused on developing novel small molecule therapeutics based on discoveries in the molecular mechanisms of aging and longevity in mammalian cells.
Location: Birmingham, MI
Foundation Cornell Technology Licensed: 2014
One Three BioTech
Category: Drug Discovery
Campus: Weill Cornell Medicine
Incubator:
OneThree Biotech is a VC backed startup developing a biology-driven Artificial Intelligence Technology Platform to accelerate drug discovery and development. The company’s platform enables the healthcare and pharmaceutical industry to quickly and accurately generate new testable insights and hypotheses by combing the world of systems and disease biology with computational tools to discover new treatments for patients in need. The platform helps identify novel targets, compounds and new drug combinations, as well as optimizes compounds for toxicity or efficacy.
Location: New York, NY
Foundation Cornell Technology Licensed: 2020
